Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance · 2 weeks ago
Open | 3.0800 |
High | 3.1300 |
Low | 2.9750 |
Mkt Cap | 513.88M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.0700 |
52 Wk. Low | 2.2300 |
52 Wk. High | 6.8900 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | -44k | - |
Net Income | -89.26M | - |
Diluted EPS | -0.51 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.41 | - |
Q4 2023 | -$0.45 | -$0.51 |
Q3 2023 | -$0.52 | -$0.37 |
S&P 500^GSPC | 5,180.74+52.95 (+1.03%) |
Dow 30^DJI | 38,852.27+176.59 (+0.46%) |
Nasdaq^IXIC | 16,349.25+192.92 (+1.19%) |
25.21+8.06% | |
3.0500+9.52% | |
116.47+2.47% |